About us
Established in February 2017, Sichuan Longevous Beamtech Co., Ltd. is a high-tech enterprise integrating R&D, production and customer service of high-end nuclear medical equipment. Longevous Beamtech is committed to becoming a global solution provider for radiopharmaceuticals.
Since its establishment, Longevous Beamtech has been concentrating on the field of nuclear medical equipment. From R&D, production to solution design, after-sales technical support, we always focus on customer needs, providing full lifecycle services. Adhering to the concept of “Customer Orientation", Longevous Beamtech insists on technology innovation and all-round customer service. Up to now, the company has obtained numerous authoritative certifications such as ISO Certifications and over 100 cyclotron-related patents, with business covering several countries and regions around the world.
The company was established in (year)
Patents and patent applications for drug preparation room (items)
Serve patients (individuals)
Equipment startup rate≥
For the health of people
Innovation Collaboration Service Precision
Provide reliable nuclear medical equipment and solutions for customers
Bring returns for investors
Create value for society
Contribute to national health
Scroll
Completed the physical design and prototype of cyclotron
Achieved localization of key components
Developed the engineering prototype of the cyclotron
Significantly improved overall performance
Established Longevous Beamtech Co.,Ltd
Officially launched the 11MeV commercial machine
Initiated the development of a series of energy spectrum products
Successfully synthesized FDG drugs
Advanced the R&D of 7MeV and 20MeV models
Stabilized production processes and established a pilot production line
Signed the first commercial contract
Installed the first cyclotron in hospital
Trial production of LB-7 and LB-20 models
Initiated R&D of the 30MeV model
Started construction of the Phase I production and R&D base
Successfully launched LB-7 and LB-20 models
Initiated R&D of the synthesis module
Phase I production and R&D base put into operation
Completed R&D of the core equipment for the 30MeV model
Achieved a market share of 30%
Signed the first overseas contract
HeadquarterMianyang
Branch OfficesBeijing, Shanghai, Guangzhou, Chengdu
Service Covered All over China, Southeast Asia, Northeast Asia and Africa
Exploring NorthAmerica, South America, Europe and Oceania
